Although the oral medications are easier to take, they have less bioavailability compared to injectable medications and may be less effective for weight loss and blood sugar control
Nature (1993) 362(6415):759
You may have a case worth reviewing if: You used Ozempic, Wegovy, Rybelsus, or another GLP-1 drug You later developed sudden vision loss, blind spots, blurred vision, or a serious optic nerve condition You were diagnosed with NAION or another serious vision-related injury Your vision problems required emergency care, specialist treatment, or ongoing follow-up You have medical records, prescription history, or ophthalmology findings linking the vision event to the period when you used the drug Your loved one suffered severe or permanent vision loss after taking one of these medications Not every eye complaint will support a lawsuit
The key advantage is portability to appointments without device dependence
A PA requirement combined with a step therapy requirement can effectively block a new entrant from gaining commercial traction even when the drug is formulary-listed, because the friction of satisfying both requirements exceeds the physicians willingness to prescribe it for most patients
